Thursday, November 05, 2009

Come Out and Enjoy a Pat Conroy Event!!



The South Carolina Autism Society Presents

The Palmetto State's Favorite Story Teller...

PAT CONROY

With Walter Edgar, Ph.D. as Master of Ceremony

A benefit supporting S.C. Autism Society's mission to enable all individuals with Autism Spectrum Disorders in South Carolina to reach their maximum potential

South Carolina State Museum
301 Gervais Street
Columbia, SC 29203
*Basic admission $75 and supporting admission $100
*Please call 803-750-6988 for more information




No Scientific Link Between Childhood Vaccines And Autism, Review Shows


ScienceDaily (Oct. 10, 2009) — A new article recently published in the Journal for Specialists in Pediatric Nursing explored vaccination history, vaccine safety monitoring systems in the U.S., and the two most publicized theoretical vaccine-related exposures associated with autism – the vaccine preservative thimerosal and the measles, mumps, and rubella (MMR) vaccine. A review of published research shows that there is not convincing scientific evidence supporting a relationship between vaccines and autism. The article is part of a special issue, which includes five articles focusing on the topic of autism. By definition, the onset of autism occurs prior to age three. No clear cause of autism has been identified, although various possible

Wednesday, November 04, 2009

Does Diabetes Speed Up Memory Loss In Alzheimer's Disease?

brain clip art
ScienceDaily (Oct. 28, 2009) — Research has shown that diabetes increases the risk of Alzheimer's disease and the risk of memory loss in people who don't have Alzheimer's disease. But it hasn't been clear whether people with Alzheimer's disease and diabetes have more rapid memory loss than those who have Alzheimer's disease but no diabetes.

New research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology, suggests that those with both diseases actually have a slower rate of memory loss than people who had only Alzheimer's disease.

"This result was surprising," said study author Caroline Sanz, MD, of INSERM, the French National Institute for Health and Medical Research in Toulouse. "Our initial hypothesis was that diabetes would increase the rate of cognitive decline in people with Alzheimer's disease."

To view the entire article, please click on the link above.

Tuesday, November 03, 2009

Why Antidepressants Don't Work For So Many

pills clip art
ScienceDaily (Oct. 27, 2009) — More than half the people who take antidepressants for depression never get relief.

Why? Because the cause of depression has been oversimplified and drugs designed to treat it aim at the wrong target, according to new research from the Northwestern University Feinberg School of Medicine. The medications are like arrows shot at the outer rings of a bull's eye instead of the center.

A study from the laboratory of long-time depression researcher Eva Redei, presented at the Neuroscience 2009 conference in Chicago this week, appears to topple two strongly held beliefs about depression. One is that stressful life events are a major cause of depression. The other is that an imbalance in neurotransmitters in the brain triggers depressive symptoms.

To view the entire article, please click on the link above.

Monday, November 02, 2009

Scientists Show How Tiny Cells Deliver Big Sound In Cochlea

illustration of cochlea
Medical illustration of the human osscous labyrinth, from "1870 Gray's Anatomy Descriptive And Surgical Book - First Edition". (Credit: iStockphoto/Mark Strozier)

ScienceDaily (Oct. 23, 2009) — Deep in the ear, 95 percent of the cells that shuttle sound to the brain are big, boisterous neurons that, to date, have explained most of what scientists know about how hearing works. Whether a rare, whisper-small second set of cells also carry signals from the inner ear to the brain and have a real role in processing sound has been a matter of debate.

Now, reporting on rat experiments in the October 22 issue of Nature, a Johns Hopkins team says it has for what is believed to be the first time managed to measure and record the elusive electrical activity of the type II neurons in the snail-shell-like structure called the cochlea. And it turns out the cells do indeed carry signals from the ear to the brain, and the sounds they likely respond to would need to be loud, such as sirens or alarms that might be even be described as painful or traumatic.

To view the entire article, please click on the link above.

Friday, October 30, 2009

Master Regulator Found For Regenerating Nerve Fibers

microscope clip art
ScienceDaily (Oct. 26, 2009) — Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems.

Their findings, published online by Nature Neuroscience on October 25, suggest Mst3b -- or agents that stimulate it -- as a possible means of treating stroke, spinal cord damage and traumatic brain injury. Normally, neurons in the central nervous system (the brain and spinal cord) cannot regenerate injured nerve fibers, limiting people's ability to recover from brain or spinal cord injuries.

To view the entire article, please click on the link above.

Thursday, October 29, 2009

Is It A Visual Problem Or Alzheimer's? New Data Helps Doctors Make The Diagnosis

ScienceDaily (Oct. 27, 2009) — Sometimes when a patient tells his ophthalmologist that he "can't see," what he really means is "I can see, but I can no longer read or write." In a minority of Alzheimer's patients the disease shows up first as problems with vision rather than memory or other cognitive functions. But diagnosis can be difficult because standard eye exams are often inconclusive for these patients.

Neuro-ophthalmologists Pierre-Francois Kaeser, MD, and Francois-Xavier Borruat, MD, Jules Gonin Eye Hospital, Switzerland, examined and followed 10 patients with unexplained vision loss who were ultimately diagnosed with the visual variant of Alzheimer's disease (VVAD). Their study -- presented at the 2009 Joint Meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology (PAAO) -- describes clinical clues that may improve ophthalmologists' ability to detect VVAD and refer patients for further tests. When patients receive neurological assessment, treatment and family counseling early in the disease, outcomes may be better for all concerned.

To view the entire article, please click on the link above.

Wednesday, October 28, 2009

Cochlear Implants Reduce Delay Suffered By Deaf Children In Language Acquisition, Study Shows

clip art of children playing
ScienceDaily (Oct. 19, 2009) — A multidisciplinary group at Malaga University, headed by Ignacio Moreno-Torres, is collecting information on the milestones that mark the development of deaf children fitted with a Cochlear Implant (CI) and studying to what extent the social and family environment affects this development. This research is funded with 101,000 euro by the Andalusian Regional Ministry of Innovation.

The researchers have observed in this first year of the study that, three months after receiving the implant all the children showed improvement in their perception and ability to detect sounds around them. Children quickly learn that the CI is a device that allows them to hear and if it is deactivated they protest or make gestures asking that it be switched back on.

To view the entire article, please click on the link above.

Tuesday, October 27, 2009

Fine-tuning Treatments For Depression

pills clip art
ScienceDaily (Oct. 18, 2009) — New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated -- a finding that may help fine-tune therapies for depression.

Current drugs for depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases.

Recent findings suggest that synucleins, a family of small proteins in the brain, are key players in the management of neurotransmitters -- specifically, alpha- and gamma-synuclein. Additionally, researchers have found elevated levels of gamma-synuclein in the brains of both depressed animals and humans.

To view the entire article, please click on the link above.

Monday, October 26, 2009

Mercury Levels In Children With Autism And Those Developing Typically Are The Same, Study Finds

chart clip art
ScienceDaily (Oct. 20, 2009) — In a large population-based study published online today, researchers at the UC Davis MIND Institute report that after adjusting for a number of factors, typically developing children and children with autism have similar levels of mercury in their blood streams. Mercury is a heavy metal found in other studies to adversely affect the developing nervous system.

The study, appearing in the journal Environmental Health Perspectives, is the most rigorous examination to date of blood-mercury levels in children with autism. The researchers cautioned, however, that the study is not an examination of whether mercury plays a role in causing the disorder.

"We looked at blood-mercury levels in children who had autism and children who did not have autism," said lead study author Irva Hertz-Picciotto, an internationally known MIND Institute researcher and professor of environmental and occupational health. "The bottom line is that blood-mercury levels in both populations were essentially the same. However, this analysis did not address a causal role, because we measured mercury after the diagnosis was made."

To view the entire article, please click on the link above.

Friday, October 23, 2009

Popular Antidepressant Associated With A Dramatic Increase In Suicidal Thoughts Amongst Men, Study Finds

pills clip art
ScienceDaily (Oct. 15, 2009) — Nortriptyline has been found to cause a ten-fold increase in suicidal thoughts in men when compared to its competitor escitalopram. These findings are published in the open access journal BMC Medicine.

The research was carried out by Dr. Nader Perroud from the Institute of Psychiatry, Kings College London, who headed up GENDEP, an international team. Dr Perroud said "Suicidal thoughts and behaviours during antidepressant treatment have prompted warnings by regulatory bodies". He continued "the aim of our study was to investigate the emergence and worsening of suicidal thoughts during treatment with two different types of antidepressant."

Both escitalopram and nortriptyline have their effect through the mood modulating neurotransmitter systems. The former is a selective serotonin reuptake inhibitor (SSRI), preventing serotonin from re-entering the cell and thereby prolonging its effect on nerve synapses. The latter is a tricyclic antidepressant that inhibits the reuptake of noradrenaline, and to a lesser extent, that of serotonin.

To view the entire article, please click on the link above.

Thursday, October 22, 2009

STAR equipment pickups coming up in South Carolina


The STAR Re-Use network inventory and pickup schedule can be found at:




Please call Walton Options or one of our STAR partners if you want to be a part of these routes. More information can be found at:

http://www.sc.edu/scatp/reutilization.html



STAR partners can be found at:

http://www.sc.edu/scatp/starnetwork.html

Redefining Dementia as a Terminal Illness

photo of holding hands

Time (Wednesday, Oct. 14, 2009) -- Dementia is most often thought of as a memory disorder, an illness of the aging mind. In its initial stages, that's true — memory loss is an early hallmark of dementia. But experts in the field say dementia is more accurately defined as fatal brain failure: a terminal disease, like cancer, that physically kills patients, not simply a mental ailment that accompanies older age.

That distinction is largely unfamiliar both to the general public and within the medical field, yet it is a crucial one when it comes to treatment decisions for end-stage dementia patients. Dr. Greg Sachs at the Indiana University Center for Aging Research says a lack of appreciation of the nature of dementia leads to misguided and often overly aggressive end-stage treatment. Five years ago, Sachs wrote a paper on such barriers to palliative end-of-life care for dementia patients, but he ran into difficulty explaining the findings to the editors of the major medical journal that published it. "The editors kept coming back to me and saying, 'But what do the patients die of? You don't die from dementia.' And I kept saying, 'Yes, they do. That's the whole point of the paper,' " says Sachs.

Now, a large, prospective study to be published in the Oct. 15 issue of the New England Journal of Medicine goes a long way toward identifying the true course of the slow-progressing disease, which affects some 5 million Americans — a number that is expected to triple by 2050. "This is the first large study to show what specialists have been arguing for years. Dementia is a terminal illness, and patients warrant palliative care," says Sachs, who wrote an editorial that appears in the same issue of the journal.

By Catherine Elton

To view the entire article, please click on the link above.